Rubicon Research Limited has raised ₹1,377.5 from an initial public offerring comprising a fresh issue and an offer for sale by General Atlantic Singapore RR Pte. Ltd., the promoter selling shareholder.
AZB & Partners advised Rubicon Research on this IPO.
The transaction team consisted of Varoon Chandra (Senior Partner), Lionel D'Almeida (Senior Partner), Rahul Aggarwal (Partner), Rajat Chadha (Senior Associate), Shweta Agrawal (Senior Associate), and Associates Yagnesh Sharma, Shivani Singh, Vaibhav Kumar Shah and Anjali Singit.
Khaitan & Co advised the Book Running Lead Managers i.e., Axis Capital Limited, IIFL Capital Services Limited, JM Financial Limited and SBI Capital Markets Limited, on this IPO.
The transaction team consisted of Subhayu Sen (Partner), Ayush Mohata (Partner), Aparna Bagree (Partner), Johann Valladares (Senior Associate), Associates Aayush Virani, Avantika Tanwar, Mehar Sharma.
White & Case served as the International Counsel for the BRLMs.
The transaction team was led by Partners Rahul Guptan (London) and Kaya Proudian (Singapore) and included Partner Steven Gee (New York), local Partner James Hsiao (Hong Kong), Associates Ji Yang Lim (Singapore), Tarang Nagar (London) and Royston Tan (Hong Kong).
Rubicon Research is a pharmaceutical formulations company based in Mumbai that specializes in developing, manufacturing, and marketing branded specialty products for pharmaceutical companies.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.